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ABSTRACT 
Objective: To evaluate the medication knowledge of the patients on maintenance hemodialysis, their adherence to drug therapy and to assess the 
effect of patient counselling in improving their medication knowledge and adherence.  
Methods: Data was obtained from the patients by medical history interview and review of their medical records. The medication knowledge was 
assessed using Medication knowledge assessment questionnaire (MKAQ) and their medication adherence behaviour using Brief Medication 
questionnaire (BMQ). Patients were counseled both verbally and by distribution of education leaflets regarding their disease, dialysis procedure, the 
drugs, diet and fluid restrictions on regular dialysis days and the effect of patient counselling in improving their medication knowledge and 
adherence was assessed using the respective questionnaires at the baseline, after 6 and 12 weeks. The mean scores were subjected to statistical 
analysis. 
Results: 85 patients (57 males and 28 females; mean age 50.52±13.28years) were included and 79% were on twice weekly and 21% were on thrice 
weekly dialysis. The average number of drugs prescribed for a patient was found to be 6.47±1.57. Hypertension was found to be the major co-
morbidity in 52.94% patients and antihypertensives were the most prescribed drugs (75.3%). Based on the mean MKAQ score, there was a 
significant increase in the medication knowledge from baseline of 14.30±6.97 to 19.32±6.61 at the end of sixth week (p=0.000) and to 33.62±7.76 at 
the end of twelfth week of counseling (p= 0.000). The mean BMQ score was 4.26±0.95 at the baseline, 2.99±0.82 on the sixth week and 1.73±0.94 on 
the twelfth week of counseling, indicating a significant improvement in medication adherence with continuous patient counseling (p=0.000).  
Conclusion: The study emphasized that provision of constant patient education to hemodialysis patients would increase the medication knowledge 
of the patients and improve their adherence.   
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INTRODUCTION 
Chronic kidney disease (CKD) is a condition with progressive loss of 
renal function and a worldwide public health problem with an 
increasing incidence and prevalence, poor outcomes, and high 
cost[1]. Hemodialysis (HD) is a viable, safe and efficient method for 
the maintenance of patients with CKD progressing to end stage renal 
disease (ESRD) and the patients are to be dialysed twice or three 
times per week for approximately 4 hours per session[2].  
Patients on maintenance hemodialysis have a complex drug regimen 
and may receive on average 10-12 medications per day, many of 
which require multiple doses/day [3]. Effective management of 
ESRD patients on hemodialysis is adherence to their therapeutic 
regimen. Medication adherence refers to the extent of patients 
taking medication and because of the demands of hemodialysis; 
many patients might not adhere to the prescribed regimen, thereby 
jeopardizing successful clinical outcomes [4]. 
Various factors are said to influence medication nonadherence in 
these patients which include; polypharmacy, frequent medication 
adjustments on dialysis versus non-dialysis days, medically unstable 
nature of the disease, lack of knowledge on the name, indication, 
dosage, frequency, side effects of the medications and restricted life 
style[5]. Studies conducted in developed countries have documented 
non adherence patterns in patients on maintenance hemodialysis. 
Results of these studies indicated that hemodialysis patients have 
inadequate knowledge and understanding about their medications 
[6].  
In addition to these reasons, ESRD itself is a life threatening 
condition, which causes physical and psychological disturbances 
(such as anxiety, stress) contributing for reduced functional capacity  
and quality of life. Assessing the medication knowledge of these 
patients and providing them with required medication related 
information would be more meaningful and beneficial. Patient 
focused interventional strategies such as identification and removal 
of barriers to medication adherence, patient education and cognitive 
behavioral strategies may improve adherence to the treatment 
regimens [7]. 
In India, studies were done on hemodialysis patients focusing almost 
exclusively on fluids and diet with little or no attention paid to 
medication and very few data are available on studies assessing 
medication knowledge and adherence of dialysis patients to 
medications [6,8]. Hence a study was conducted with the objective of 
assessing the medication knowledge of CKD patients undergoing 
maintenance hemodialysis, to assess the effect of a clinical 
pharmacist provided continuous patient education in improving 
medication adherence and to evaluate the association between 
medication knowledge and medication adherence behaviour in 
hemodialysis patients.  
MATERIALS AND METHODS 
The study was conducted in patients of either sex, aged above18 
years, undergoing twice/thrice weekly maintenance hemodialysis 
on outpatient basis and was receiving their scheduled medication 
regimen in the dialysis unit of a South Indian multispecialty 
University hospital and consenting to participate in the study after 
obtaining approval of the institutional ethics committee. Patients 
with multiple organ system failure, loss of consciousness, memory 
impairment, severely disabled, malignancies, irregular dialysis, 
patients   who were   unable to   speak/understand English or local 
language (Tamil) were excluded from the study.  
Data including Patient demographics (age, sex), past medical & 
medication history, duration and frequency of dialysis, medications 
prescribed [name, dose, frequency, route, duration of the drug] were 
obtained by direct patient history interview and review of the 
patient medical records and documented in the data collection forms 
specially designed for the study. Patients were counseled verbally 
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(15-30 min/patient) on their regular dialysis days regarding their 
disease, dialysis procedure, the drugs, diet and fluid restrictions. 
Patient education leaflets were prepared in English and vernacular 
language (Tamil) and distributed to the patients on the first episode 
of counseling.  
Patients’ medication knowledge was assessed using a validated 
interviewer administered Medication knowledge assessment 
questionnaire (MKAQ) [8]. The questionnaire consists of 5 questions 
and two columns named as ‘actual’ and ‘patient’ for each question. 
The ‘actual’ column contains the current actual list of the 
medications taken by the patient. This column was filled by the 
interviewer before interviewing the patient by referring to patients’ 
case records and dairies. An interview was conducted for each 
patient in a single session of 20-30 min to assess the parameters like 
ability of each patient to recall the names of his/her medications, the 
purpose of use (indication), dose/strength, the number of doses to 
be taken each time and side effects of their medications and the 
responses were used to score questions 1 to 4 separately in the 
corresponding “patient” column. If the patient recalled only one of 
the parameter without recalling the other three parameters it was 
considered as true knowledge. Question number five does not have a 
scoring system hence it was not scored. 
The medication adherence pattern of the patients was assessed 
using Brief medication questionnaire (BMQ) [9], to assess the 
reported medication adherence behavior of the study subjects. BMQ 
consists of three screens: 5-item Regimen Screen that asks patients 
how they took each medication in the past week, a 2-item Belief 
Screen that asks about drug effects and bothersome features, and a 
2-item Recall Screen about potential difficulties remembering. All 
these BMQ screens consist of a positive and negative screen. A score 
of ≥ 01 denote a positive screen representing the patient reported 
non-adherence regarding his/her medication regimen, while a score 
zero denote a negative screen, signified patient adherence to the 
prescribed medication regimen. The higher the BMQ score, the 
higher the reported rate of non-adherence. Both the questionnaires 
were administered at the baseline, on the sixth week and on the 
twelfth week. The responses obtained from the patients were scored 
as stated in the questionnaires and were subjected to statistical 
analysis. 
Statistical analysis 
 The association between patient education, reported medication 
adherence pattern and patients’ knowledge about the medications 
was examined using the two tailed independent paired T- test. The 
correlation between patients medication knowledge and medication 
adherence was assessed using Pearson’s correlation coefficient. A p 
value of < 0.05 was considered statistically significant.  
RESULTS 
 A total of 85 patients were included in the study of which, 57 were 
males and 28 were females in the age range of 18-80 years (mean 
age of 50.52±13.28years). 31 (36.5%) patients were in the age range 
of 51-60 years, 19 (22.4%) were in the age range of 61 to 70 years. 
Of 85 patients, 67 (78.82%) patients were undergoing twice weekly 
dialysis and 15(17.64%) were on thrice weekly dialysis. The total 
number of medications prescribed per prescription was found to be 
5 to 6 medications in 37(43.52%) patients; 7 to 8 medications in 
35(41.17%) patients; 2 to 4 medications in 7(8.23%) and 9 to 10 
medications in 5(5.88%) patients. Only 1(1.17%) patient received 
more than 10 medications. The average number of drugs prescribed 
for a patient was found to be 6.47±1.57. Hypertension was the co 
morbidity found in majority of the patients 45(52.94%), followed by 
diabetes and hypertension in 27(31.76%) patients, nephropathy in 
6(7.05%) patients, diabetes alone in 5(5.88%) patients, CAD and left 
ventricular dysfunction in 3(3.52%) patients, bronchial asthma in 
1(1.17%) patient and tuberculosis in 2(2.35%) patients. 
Table 1 shows the antihypertensives prescribed for the study. 
64(75.29%) patients received calcium channel blockers, 30(35.29%) 
patients were on loop diuretics, (25.88%) patients were on beta 
blockers, 20(23.52%) patients were on alpha adrenergic agonist 
clonidine, 12(14.11%) patients received alpha adreno receptor 
blocker Prazosin and 4(4.70%) patients received angiotensin II 
receptor antagonist Losartan. 
Table 1: Antihypertensives Prescribed in Study Population 
 
ANTIHYPERTENSIVES 
NO OF PATIENTS 
(N=85) 
                
(n) 
TOTAL 
(n)          (%) 
Calcium channel blockers 
   Nifedipine 




     
 64        75.29        
Loop diuretics 
  Furosemide 





30           35.29         
Beta blockers 
  Atenolol 
  Carvedilol 
  Metaprolol 








 22         25.88            
Alpha 2 adrenergic agonist 




20         23.52            
Alpha 1 adreno receptor 
blocker 






12        14.11 
Angiotensin II receptor 
antagonist 
  Losartan 
 
                   
4 
    
 
4            4.70            
Table 2 shows the other classes of medications prescribed for the 
study population which included vitamin preparations for 
65(76.47%) patients, proton pump inhibitors for 58(68.23%) 
patients, calcium supplements for 47(55.29%) patients, 
erythropoietin for 46(54.11%) patients, antiplatelets for 
16(18.82%) patients, nitrates for 13(15.29%) patients, lipid 
lowering agents  for 12(14.11%) patients, H2 receptor blockers for 
8(9.41%) patients, anxiolytics for 7(8.23%) patients, phosphate 
binders for 6(7.05%) patients, allopurinol for 5(5.88%) patients, 
antibacterials, anticonvulsants, laxatives and antiemetics for 
4(4.70%) patients each and steroid prednisolone for 3(3.52%)  
patients.  
Table 2: Other Medications Prescribed in Study Population 
 
OTHER CLASS OF 
MEDICATIONS 
NO OF PATIENTS 
(N=85) 
n (n)                  (%) 
Vitamins 65 65                 76.47 
Proton pump inhibitors 
  Pantoprazole 
  Omeprazole 







58                68.23 
Calcium supplements 
  Calcium acetate 





47               55.29 






16                18.82 
Nitrates 
  Isosorbide dinitrate 
  Glyceryl trinitrate 







13               15.29 
Lipid lowering agents 
  Lovastatin 





12            14.11                
H2 receptor blocker     




8               9.41 
Anxiolytics 
  Alprazolam 
  Clonazepam 
  Nitrazepam 








7            8.23 
Phosphate binders 




6            7.05 
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  Lanthanum carbonate 2 
Antigout (Allopurinol) 5 5            5.88 
Antibacterials 
  Isoniazid & Rifampacin 






4            4.70 
Anticonvulsants 
  Phenytoin 
  Pregabalin 
  Valproate 








4            4.70  
Laxative (Lactulose) 4 4           4.70 
Antiemetics 
  Ondonsetron 











   
3            3.52 
 
The mean MKAQ scores and the statistical analysis of difference in 
the mean scores at the baseline, sixth week and twelfth week were 
assessed. The mean MKAQ score before initiation of patient 
counseling was found to be 45.07±7.93, on the sixth week of patient 
counseling was 59.37±6.87 and on twelfth week of patient 
counseling was 78.69±6.76 (Table 3). There was a statistically 
significant increase in the mean MKAQ score from baseline of 
14.30±6.97 to 19.32±6.61 at the end of sixth week of counseling 
(p=0.000) and to 33.62±7.76 at the end of twelfth week of patient 
counseling (p= 0.000) (Table 4). 
 Table 3: Mean Scores of Medication Knowledge 
Assessment Questionnaire (MKAQ) 
MKAQ assessment 
duration 
Mean Score ± Standard 
Deviation 
Baseline 45.0715 ±7.93088 
6th week 59.3799 ± 6.87017 
12th week 78.697 ± 6.7621 
 
Table 4: Statistical Analysis of Mean MKAQ Scores 
MKAQ  
Mean Score ± 
Standard Deviation 








6th  week 
14.30835 ± 6.97496 15.81282 12.80389 18.913 0.000* 
Baseline- 
12th  week 
33.62541 ± 7.75820 35.29882 31.95201 39.959 0.000* 
6th week- 
12th week 
19.31706 ± 6.61438 20.74375 17.89037 26.925 0.000* 
*Statistical significance 
The assessment of the medication adherence behavior of the 
patients done using BMQ scores revealed the following: the mean 
BMQ score was 4.26±0.95 at the baseline, 2.99±0.82 on the sixth 
week of counseling and 1.73±0.94 on the twelfth week of counseling 
(Table 5). The statistical analysis performed to assess the 
association between patient counseling and medication adherence 
was found to be highly significant (p=0.000). There was a significant 
drop in the BMQ scores from the baseline to the sixth and twelfth 
week of counseling (Table 6). 
Table 5:  Mean Scores of Brief Medication Questionnaire (BMQ) 
BMQ assessment 
duration  
Mean Score ± Standard 
deviation 
Baseline 4.26 ± 0.953 
6th week 2.99 ± 0.824 
12th week 1.73 ± 0.944 




Mean Score ± 
Standard deviation 








6th  week 
1.271± 0.662 1.128 1.413 17.704 0.000* 
Baseline- 
12th  week 
2.529 ± 0.853 2.345 2.713 27.326 0.000* 
6th week- 
12th week 
1.259 ± 0.538 1.143 1.375 21.575 0.000* 
* Statistical significance 
There was a negative correlation between medication knowledge 
and medication adherence behavior of the study population                
(r = -0.025) based on the Pearson correlation coefficient analysis 
indicating that there was not statistically significant association 
(p=0.817) between medication knowledge and adherence (Table 7). 
Table 7: Correlation of Mean MKAQ and Mean BMQ Scores 
Correlation  Mean score ± S.D R P 
MKAQ-12 Weeks   78.697 ± 6.76 -0.025 0.817 
 BMQ-12 Weeks  1.73 ± 0.944 
 
DISCUSSION 
ESRD is a chronic disease that affects many people all over the world 
and is associated with a high morbidity and mortality. ESRD patients 
on maintenance hemodialysis, have co morbidities that require 
multiple medications which lead to poor adherence. A study was 
done to assess the effect of pharmacist provided patient education in 
improving patients’ knowledge of their medications and their 
adherence toward the treatment.  
Majority of the patients (53%) were in the age group of 51 years and 
above in the study and were on 6 medications per day on an average.  
This is in consistence with other studies [3, 6],  which have reported 
that older adults have higher prevalence of CKD and the average of 7 
medications were prescribed per patient. Hemodialysis patients 
have multiple co morbid conditions which often necessitates the use 
of many drugs. Almost 50% of the patients in this study had 
hypertension as co-morbidity and around 32% had both 
hypertension and diabetes necessitating the use of antihypertensive 
medications in majority of the patients. 
The present study assessed the medication knowledge of 
hemodialysis patients using MKAQ questionnaire at the baseline and 
at the end of 6th and 12th weeks, after providing with structured 
education about their medications continuously for 12 weeks. The 
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study observed a significant improvement (p=0.000) in the 
medication knowledge of these patients from baseline to the twelfth 
week after continuous education. During the baseline assessment of 
medication knowledge, some patients had a poor knowledge about 
the name and strength of the medications given to them and also had 
a negative belief towards the medication usage as they thought that 
it was not so important to adhere to the instructions given to them 
regarding the doses, dosing interval, dosing frequency of the 
medications they were taking.   
The knowledge about the indications of all the medications they 
were taking was also low. Majority of the patients were aware of the 
indications for the antihypertensive medications, calcium 
supplements and erythropoietin than for other class of medications 
like phosphate binders, proton pump inhibitors, lipid lowering drugs 
and others. These observations are in accordance to that reported by 
Sathvik B S., et al [8] and Cleary, et al. [10], who found that majority 
of the dialysis patients knew the indication for their 
antihypertensive medications than for their phosphate binders. 
These findings were also consistent with the findings of Lim A., [10] 
where the author reported that medication knowledge of the dialysis 
patients was deficient particularly about their phosphate binders 
and Vitamin D. 
Medication adherence has a correlation with medication knowledge 
[12]. In this study compared to baseline, there was a significant 
reduction in the mean BMQ regimen, belief & recall Screens scores 
after the sixth and twelfth week of education sessions provided by 
the clinical pharmacist. Considering the mean BMQ medication 
screen scores as an adherence determining parameter, the extent of 
nonadherence was found to decrease significantly (p=0.000) after 
the counseling sessions provided by the clinical pharmacist.  
In this study, prior to patient education sessions, majority of study 
patients had limited knowledge/poor understanding of the exact 
role of all the medications they were taking. Insufficient and poor 
understanding of the prescribed medications has been reported in 
the literature as possible cause of nonadherence [13,14]. Research 
has consistently demonstrated that patients’ understanding of their 
conditions and medications is positively related to adherence [15]. 
But there was no significant association between medication 
knowledge and adherence behavior towards medications in this 
study (p=0.817) indicating that other factors like patient 
demographic parameters like gender, age, socioeconomic status and 
literacy status, duration of dialysis, and number of medications also 
influence the medication adherence pattern of the patients. The 
major limitation of this study is that it did not assess the association 
of these factors with medication knowledge and adherence behavior 
of the patients. A study done by Jean K., et al [16] had found that the 
lack of patient education about medications was not an important 
factor in medication nonadherence but the number of daily 
medications (typically more than 11) and lack of funds were found 
to be the most common reasons.  
The reasons for medication nonadherence among dialysis patients 
were reported in earlier studies as both the complexity of the 
medication regimens and the need to be taken throughout life. 
Adherence decreases as the complexity and duration of the regimen 
increases. The consequences of poor adherence include poor health 
outcomes and increased health care costs [17]. 
The study emphasizes that provision of constant patient education 
to hemodialysis patients would increase the medication knowledge 
of the patients and improve their adherence.  It is also essential to 
identify other factors leading to poor adherence to medication 
regimens as it would be beneficial for healthcare professionals to 
recognize patients who may benefit from interventions to improve 
medication adherence. By making patients understand the 
significance of the medications being prescribed for them, an 
increased adherence with long-term medication therapies can be 
achieved. Emphasis should also be made on the effects of missing 
medications on the patient’s health care outcomes.  
CONCLUSION 
Medication adherence is a major issue posing a greater burden on 
management of ESRD. The involvement of the clinical pharmacist in 
the dialysis unit in providing patient education can improve patient 
adherence towards the medication by improving their knowledge 
towards their medications and thereby lessen the burden of the 
prescribing physicians.  
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